Robert Orlowski, Deputy Chair of Lymphoma/Myeloma, Vice Chair of MM Research, and Florence Maude Thomas Cancer Research Professor at the University of Texas MD Anderson Cancer Center, shared a post on X:
“Myeloma Paper of the Day:
Plant-based whole-food diets are feasible during auto-HCT and associated w/ dose-dependent microbiome modulation, including enrichment of SCFA-producing taxa and compositional changes consistent w/ fiber-responsive microbiome.”
Title: Plant-based whole-food diets are feasible during auto-HCT and are associated with dose-dependent microbiome modulation
Authors: Katherine Ueland, Taara Elahi, Mary Rasmussen, Alex Wolfe, Hayley Purcell, Saranya Chakka, Mercy Mirimo-Martinez, Heather Persinger, Karen Johnson, Alanna Boynton, Kerry McMillen, Mariia Byelykh, Melinda Biernacki, Albert Yeh, Naveed Ali, Shivaprasad Manjappa, Natalie Wuliji, David Fredricks, Marie Bleakley, Leona Holmberg, Jonathan Peled, Jeannette Schenk, Daniel Raftery, Jing Ma, Geoffrey Hill, Marian Neuhouser, Stephanie Lee, Kate Markey
You can read the Full Article on Blood Advances.
You can find other articles featuring Robert Orlowski on OncoDaily.